Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015686
Filing Date
2025-06-04
Accepted
2025-06-04 20:04:41
Documents
1
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 form4-06052025_120638.html 4  
1 form4-06052025_120638.xml 4 7223
  Complete submission text file 0001415889-25-015686.txt   8623
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Issuer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 13F-2, NO. 36, LANE 48, SECTION 3 NAN-JING EAST ROAD TAIPEI, TAIWAN F4 00000
Business Address
Lee Howard (Reporting) CIK: 0001379941 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36509 | Film No.: 251024745